0,885  0,002  Dopamine D2 agonist
0,846  0,003  Dopamine agonist
0,822  0,003  5 Hydroxytryptamine 7 antagonist
0,812  0,002  Dopamine D1 antagonist
0,778  0,004  5 Hydroxytryptamine release stimulant
0,776  0,002  Dopamine D5 antagonist
0,771  0,003  Muscle relaxant
0,748  0,003  Skeletal muscle relaxant
0,740  0,006  Antiparkinsonian
0,734  0,004  Dopamine antagonist
0,698  0,004  Dopamine D2 antagonist
0,684  0,011  Respiratory analeptic
0,675  0,008  UGT1A9 substrate
0,675  0,010  Antidepressant
0,651  0,005  5 Hydroxytryptamine antagonist
0,657  0,013  Mood disorders treatment
0,647  0,011  Antipsychotic
0,626  0,003  Alpha 2b adrenoreceptor antagonist
0,621  0,003  Tyrosine 3 hydroxylase inhibitor
0,627  0,013  Vasodilator, peripheral
0,624  0,011  Spasmolytic
0,612  0,003  Alpha 2a adrenoreceptor antagonist
0,605  0,004  5 Hydroxytryptamine 1 antagonist
0,604  0,004  5 Hydroxytryptamine 1A antagonist
0,604  0,004  5 Hydroxytryptamine 2 antagonist
0,597  0,004  Sigma receptor agonist
0,592  0,004  5 Hydroxytryptamine 2B antagonist
0,585  0,005  Sedative
0,580  0,004  Alpha 2 adrenoreceptor antagonist
0,565  0,005  Alpha adrenoreceptor antagonist
0,552  0,009  Antineoplastic enhancer
0,546  0,004  5 Hydroxytryptamine 2A antagonist
0,544  0,004  Pneumotoxic
0,572  0,034  Antineoplastic (lung cancer)
0,540  0,003  Alpha 2c adrenoreceptor antagonist
0,539  0,004  5 Hydroxytryptamine 1F antagonist
0,555  0,028  Antineoplastic (colorectal cancer)
0,544  0,018  Analeptic
0,550  0,026  Aldehyde oxidase inhibitor
0,551  0,027  Antineoplastic (colon cancer)
0,528  0,012  Hypoxia-inducible factor 1 alpha inhibitor
0,555  0,044  Caspase 9 stimulant
0,513  0,005  Antiparkinsonian, rigidity relieving
0,534  0,026  Prostate cancer treatment
0,510  0,006  Cyclic AMP phosphodiesterase inhibitor
0,518  0,014  Cardiodepressant
0,513  0,012  Dependence treatment
0,503  0,005  Male reproductive disfunction treatment
0,500  0,003  5 Hydroxytryptamine 5A antagonist
0,515  0,023  CYP2D6 substrate
0,485  0,003  5 Hydroxytryptamine 5 antagonist
0,481  0,006  Calcium channel activator
0,476  0,005  Toxic, respiratory center
0,461  0,004  Dopamine D3 antagonist
0,461  0,004  Antitussive
0,475  0,019  CYP2D6 inhibitor
0,458  0,005  Erectile dysfunction treatment
0,499  0,054  Antineoplastic (breast cancer)
0,487  0,046  Transcription factor NF kappa B inhibitor
0,449  0,010  Tubulin antagonist
0,443  0,005  Alpha 1 adrenoreceptor antagonist
0,473  0,046  CYP3A4 substrate
0,498  0,075  Apoptosis agonist
0,463  0,047  Antileukemic
0,425  0,009  Cholinergic
0,472  0,058  Analgesic
0,419  0,005  Dopamine D4 antagonist
0,430  0,019  Vasodilator
0,451  0,049  Histamine release inhibitor
0,421  0,020  Antimitotic
0,444  0,042  CYP2C19 inhibitor
0,406  0,011  UGT1A3 substrate
0,396  0,005  Sigma receptor antagonist
0,394  0,005  Acetylcholine nicotinic antagonist
0,390  0,005  5 Hydroxytryptamine 1E antagonist
0,406  0,021  Psychostimulant
0,421  0,038  CYP2C19 substrate
0,407  0,026  Antipyretic
0,386  0,013  Antimigraine
0,374  0,006  Alpha 1a adrenoreceptor antagonist
0,408  0,042  Anxiolytic
0,368  0,004  Opioid kappa receptor antagonist
0,399  0,038  Cardioprotectant
0,412  0,054  Cognition disorders treatment
0,364  0,009  Antiparkinsonian, tremor relieving
0,362  0,010  Antiadrenergic
0,353  0,002  Prolactin inhibitor
0,364  0,014  Antineoplastic (squamous cell carcinoma)
0,360  0,013  Antialcoholic
0,364  0,031  FMO3 substrate
0,339  0,007  5 Hydroxytryptamine 2C antagonist
0,348  0,021  P-glycoprotein inhibitor
0,338  0,011  Adrenaline antagonist
0,334  0,010  Acetylcholine M1 receptor antagonist
0,345  0,025  Anesthetic general
0,328  0,010  Acetylcholinesterase inhibitor
0,340  0,027  Antiarrhythmic
0,323  0,012  Cholinergic antagonist
0,379  0,070  CYP2C9 substrate
0,319  0,012  Acetylcholine antagonist
0,341  0,035  Flavin-containing monooxygenase substrate
0,355  0,050  CYP1A2 substrate
0,310  0,005  Neuronal nicotinic receptor antagonist
0,308  0,007  Neuropathy treatment
0,303  0,008  LDLR expression enhancer
0,295  0,002  Dopamine D1 agonist
0,294  0,004  Myasthenia Gravis treatment
0,376  0,087  TNF expression inhibitor
0,291  0,005  5 Hydroxytryptamine 1B antagonist
0,308  0,025  UGT2B7 substrate
0,285  0,012  Cocaine dependence treatment
0,277  0,005  5 Hydroxytryptamine 1D antagonist
0,316  0,048  Tumour necrosis factor alpha release inhibitor
0,307  0,041  5 Hydroxytryptamine uptake stimulant
0,265  0,006  Alpha 1d adrenoreceptor antagonist
0,260  0,004  Antineoplastic alkaloid
0,366  0,116  Alzheimer's disease treatment
0,307  0,058  UGT2B4 substrate
0,258  0,010  5 Hydroxytryptamine agonist
0,318  0,070  Caspase 3 stimulant
0,371  0,124  Antineoplastic (solid tumors)
0,267  0,025  Antineoplastic (gastric cancer)
0,259  0,018  Antidiarrheal
0,278  0,038  UGT1A1 substrate
0,252  0,013  VEGF expression inhibitor
0,310  0,071  Sodium/bile acid cotransporter inhibitor
0,246  0,009  Constipation treatment
0,240  0,003  5 Hydroxytryptamine 7 agonist
0,237  0,004  5 Hydroxytryptamine 2 agonist
0,240  0,009  Opioid antagonist
0,259  0,028  Antineoplastic (carcinoma)
0,303  0,072  Antineoplastic (ovarian cancer)
0,240  0,011  Alpha 1b adrenoreceptor antagonist
0,249  0,020  Aldehyde oxidase substrate
0,302  0,077  CYP3A4 inhibitor
0,334  0,109  15-Lipoxygenase inhibitor
0,243  0,022  UGT2B9 substrate
0,239  0,022  Anesthetic local
0,255  0,040  UGT1A4 substrate
0,234  0,021  Uterine stimulant
0,283  0,071  Antihypoxic
0,287  0,075  Antineoplastic (melanoma)
0,224  0,016  Antismoking
0,271  0,063  Antineoplastic (liver cancer)
0,255  0,048  UDP-glucuronosyltransferase substrate
0,223  0,016  Expectorant
0,334  0,130  5 Hydroxytryptamine release inhibitor
0,211  0,008  Alpha adrenoreceptor agonist
0,210  0,007  Beta tubulin antagonist
0,206  0,004  Nicotinic receptor alpha7 subunit antagonist
0,205  0,004  Restless leg syndrome treatment
0,230  0,029  Antidote
0,208  0,008  Opioid mu receptor antagonist
0,303  0,104  Stroke treatment
0,291  0,094  Antithrombotic
0,205  0,009  Analgesic, opioid
0,302  0,106  Ulceration
0,265  0,073  DNA damaging
0,198  0,006  Alpha 1 adrenoreceptor agonist
0,217  0,026  UGT2B10 substrate
0,202  0,013  Calcium antagonist
0,257  0,068  Antiamyloidogenic
0,235  0,049  Sleep disorders treatment
0,256  0,073  Antineoplastic (bladder cancer)
0,188  0,005  Alpha 2 adrenoreceptor agonist
0,194  0,012  Opioid delta receptor antagonist
0,259  0,077  Amyotrophic lateral sclerosis treatment
0,255  0,075  Antineoplastic (non-small cell lung cancer)
0,186  0,008  Tocolytic
0,182  0,005  Opioid mu receptor agonist
0,208  0,032  Toll-Like receptor 9 antagonist
0,212  0,038  Antiischemic, cerebral
0,183  0,011  Antiviral (Papilloma)
0,197  0,025  Acetylcholine muscarinic antagonist
0,198  0,027  Alkylator
0,181  0,009  5 Hydroxytryptamine 1A agonist
0,204  0,034  Genotoxic
0,223  0,053  Hepatoprotectant
0,180  0,012  5 Hydroxytryptamine 1 agonist
0,246  0,080  Antihypercholesterolemic
0,244  0,078  Superoxide dismutase inhibitor
0,242  0,078  Antineoplastic (glioma)
0,290  0,128  Antipruritic, allergic
0,162  0,002  Prolactin release inhibitor
0,163  0,005  Opioid kappa receptor agonist
0,164  0,006  Opioid agonist
0,248  0,094  Radioprotector
0,171  0,020  Obsessive-compulsive disorder treatment
0,239  0,090  Cardiotonic
0,154  0,005  5 Hydroxytryptamine 6 antagonist
0,229  0,082  Teratogen
0,227  0,085  Antineoplastic (cervical cancer)
0,180  0,040  M18 aspartyl aminopeptidase inhibitor
0,168  0,028  Butyrylcholinesterase inhibitor
0,225  0,085  NOS2 expression inhibitor
0,146  0,006  Narcotic antagonist
0,153  0,015  Acetylcholine release stimulant
0,146  0,010  Alpha tubulin antagonist
0,182  0,046  Anesthetic
0,169  0,033  Antiprotozoal (Amoeba)
0,143  0,009  Nicotinic alpha4beta2 receptor antagonist
0,140  0,006  5 Hydroxytryptamine 2A agonist
0,216  0,085  Free radical scavenger
0,206  0,076  DNA methylase inhibitor
0,219  0,090  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,232  0,104  Antineoplastic (pancreatic cancer)
0,222  0,096  Antineoplastic (sarcoma)
0,195  0,070  Mutagenic
0,130  0,005  Sigma 1 receptor antagonist
0,229  0,107  Radiosensitizer
0,154  0,032  Nav1.1 sodium channel blocker
0,209  0,087  UGT1A6 substrate
0,141  0,019  Phosphodiesterase I inhibitor
0,261  0,140  Immunosuppressant
0,173  0,054  Carcinogenic, group 1
0,123  0,005  5 Hydroxytryptamine 1B agonist
0,120  0,004  Sigma 2 receptor antagonist
0,163  0,047  Toll-Like receptor antagonist
0,190  0,079  Abortion inducer
0,114  0,005  5 Hydroxytryptamine 4 antagonist
0,123  0,016  Female sexual dysfunction treatment
0,166  0,059  UGT2B15 substrate
0,111  0,005  Potassium channel small-conductance Ca-activated blocker
0,205  0,103  Acute neurologic disorders treatment
0,121  0,020  Phosphodiesterase XI inhibitor
0,121  0,020  Phosphodiesterase 11A inhibitor
0,162  0,062  NOS3 expression enhancer
0,194  0,094  Embryotoxic
0,199  0,100  Cytostatic
0,239  0,140  FMO1 substrate
0,160  0,062  Protein kinase stimulant
0,116  0,019  Acetylcholine M4 receptor antagonist
0,134  0,038  AMP-activated protein kinase stimulant
0,201  0,106  Cardiovascular analeptic
0,110  0,016  Dopamine uptake inhibitor
0,157  0,064  Lipid peroxidase inhibitor
0,105  0,012  Uterine relaxant
0,162  0,070  Antimutagenic
0,130  0,039  Bronchodilator
0,098  0,008  Nicotinic receptor alpha4 subunit antagonist
0,094  0,005  5 Hydroxytryptamine 3B antagonist
0,098  0,010  Nicotinic receptor alpha3 subunit antagonist
0,221  0,133  Hepatic disorders treatment
0,197  0,111  Antihypotensive
0,115  0,029  Acetylcholine nicotinic agonist
0,094  0,009  Nicotinic alpha3beta2 receptor antagonist
0,181  0,096  Antineoplastic (glioblastoma multiforme)
0,124  0,042  Electron transport complex I inhibitor
0,197  0,116  Antioxidant
0,223  0,144  GST M1-1 substrate
0,122  0,043  Vasculitis treatment
0,115  0,037  Tourette's syndrome treatment
0,160  0,085  ATPase inhibitor
0,171  0,096  CYP2B6 inhibitor
0,087  0,014  Potassium channel (Ca-activated) blocker
0,120  0,048  UGT2B1 substrate
0,221  0,148  Antihypertensive
0,115  0,043  Breast cancer-resistant protein inhibitor
0,118  0,046  Antiemetic
0,228  0,156  Vasodilator, coronary
0,110  0,038  Histamine N-methyltransferase inhibitor
0,175  0,104  Neurotrophic factor enhancer
0,093  0,023  Antidote, organophosphates
0,188  0,119  RNA-directed DNA polymerase inhibitor
0,080  0,011  5 Hydroxytryptamine 2C agonist
0,083  0,015  Phosphodiesterase 1A inhibitor
0,086  0,018  Dopamine D4 agonist
0,093  0,025  Acetylcholine M5 receptor agonist
0,123  0,057  Microtubule formation inhibitor
0,107  0,042  Acetylcholine agonist
0,082  0,016  Dopamine transporter inhibitor
0,083  0,021  Phosphodiesterase 1B inhibitor
0,109  0,046  UGT2B11 substrate
0,117  0,056  Choleretic
0,115  0,055  Multidrug resistance-associated protein 1 inhibitor
0,152  0,092  Antipruritic
0,070  0,011  Dopamine D3 agonist
0,178  0,119  VCAM1 expression inhibitor
0,096  0,038  mTOR complex 2 inhibitor
0,134  0,075  Nav1.6 sodium channel blocker
0,212  0,156  CTGF expression inhibitor
0,137  0,084  Ca2+-transporting ATPase inhibitor
0,114  0,061  5 Hydroxytryptamine 3A agonist
0,131  0,079  Neurotrophic factor
0,065  0,014  Factor III inhibitor
0,055  0,005  Nicotinic alpha3beta4 receptor agonist
0,059  0,009  5 Hydroxytryptamine 2B agonist
0,111  0,061  Protein kinase C gamma inhibitor
0,155  0,106  Phobic disorders treatment
0,092  0,043  Antiprotozoal activity enhancer
0,121  0,073  Antiseptic
0,146  0,098  Nitric oxide antagonist
0,075  0,027  5 Hydroxytryptamine 3 antagonist
0,112  0,064  Cystathionine beta-synthase inhibitor
0,152  0,104  Cytotoxic
0,124  0,078  NADPH oxidase inhibitor
0,219  0,173  Antiprotozoal (Plasmodium)
0,149  0,103  Tumour necrosis factor antagonist
0,123  0,078  Antineoplastic (uterine cancer)
0,105  0,062  Toll-Like receptor 4 antagonist
0,147  0,105  Sensitization
0,080  0,039  Calcium channel L-type blocker
0,069  0,030  Calcium channel P-type blocker
0,068  0,029  Nicotinic neuronal receptor agonist
0,095  0,057  Protein kinase C zeta inhibitor
0,164  0,126  Potassium channel (Voltage-sensitive) blocker
0,051  0,013  Opioid delta receptor agonist
0,085  0,049  Glycine receptor antagonist
0,042  0,007  Nicotinic alpha4beta2 receptor agonist
0,042  0,007  5 Hydroxytryptamine 6 agonist
0,139  0,104  Prostate disorders treatment
0,048  0,014  Vesicle monoamine transporter inhibitor
0,094  0,061  Alpha 2d adrenoreceptor antagonist
0,066  0,034  Acetylcholine M5 receptor antagonist
0,084  0,053  Histamine H1 receptor antagonist
0,034  0,004  NMDA receptor phencyclidine site antagonist
0,122  0,093  Psychosexual dysfunction treatment
0,066  0,040  Acetylcholine M2 receptor antagonist
0,119  0,097  Activin receptor-like kinase 2 inhibitor
0,143  0,121  Pyruvate kinase inhibitor
0,105  0,084  Menstruation disorders treatment
0,187  0,166  Prostaglandin dehydrogenase inhibitor
0,060  0,039  Ryanodine receptor antagonist
0,042  0,021  Nicotinic receptor beta4 subunit antagonist
0,062  0,042  NMDA 2C receptor antagonist
0,067  0,048  Glutamate (mGluR7) antagonist
0,024  0,005  Nicotinic alpha4 receptor agonist
0,066  0,047  Orexin receptor antagonist
0,090  0,072  Sphingomyelinase inhibitor
0,064  0,046  Beta 3 adrenoreceptor antagonist
0,097  0,079  EphA2 antagonist
0,036  0,019  Melatonin 2 agonist
0,093  0,076  Topoisomerase I inhibitor
0,046  0,029  Poly(ADP-ribose) polymerase inhibitor
0,042  0,026  Acid-sensing ion channel blocker
0,041  0,026  Dopamine D5 agonist
0,085  0,070  Paget's disease treatment
0,092  0,077  Glutamate (mGluR7) agonist
0,070  0,055  Orexin receptor 1 antagonist
0,028  0,014  Dopamine autoreceptor agonist
0,086  0,072  Glutamate release inhibitor
0,105  0,092  Nav1.3 sodium channel blocker
0,066  0,054  Histidine decarboxylase inhibitor
0,126  0,114  GABA C receptor rho-2 antagonist
0,047  0,037  Topoisomerase II beta inhibitor
0,051  0,041  Alpha 1L adrenoreceptor antagonist
0,026  0,017  5 Hydroxytryptamine 1F agonist
0,034  0,026  Adenosine uptake inhibitor
0,059  0,051  Phosphodiesterase 1C inhibitor
0,050  0,043  Acetylcholine muscarinic agonist
0,050  0,043  Nicotinic alpha7 receptor agonist
0,036  0,029  Poly(ADP-ribose) polymerase 1 inhibitor
0,048  0,042  Glucose-6-phosphate translocase inhibitor
0,039  0,035  Guanylate cyclase inhibitor
0,120  0,115  MAP3K9 inhibitor
0,131  0,128  DNA methyltransferase I inhibitor
0,037  0,035  Phenylethanolamine N methyltransferase inhibitor
0,141  0,140  HERG channel blocker
0,089  0,088  mTOR complex 1 inhibitor
0,025  0,024  5 Hydroxytryptamine 1D agonist

